Cybin (HELP) Asset Writedowns and Impairment (2025)
Cybin (HELP) posted quarterly Asset Writedowns and Impairment of -$7000.0 for Q2 2025.
Cybin (HELP) Asset Writedowns and Impairment (2025) Analysis & Trends
Cybin (HELP) has reported Asset Writedowns and Impairment for 1 consecutive years, with -$7000.0 the latest figure, recorded in Q2 2025.
- Quarterly Asset Writedowns and Impairment changed N/A year-over-year to -$7000.0 in Q2 2025, while the trailing twelve-month figure through Mar 2026 was -$7000.0 (changed N/A YoY) and the FY2026 annual result came in at -$7000.0, changed N/A from the prior year.
- Asset Writedowns and Impairment was little changed at -$7000.0 in Q2 2025 per HELP's latest filing.
- Over the last five years, Asset Writedowns and Impairment for HELP reached as high as -$7000.0 in Q2 2025 and fell as low as -$7000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -7,000.00 |
| Jun 30, 2025 | -7,000.00 |